159 related articles for article (PubMed ID: 21537303)
21. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
Bernier J; Russi EG; Homey B; Merlano MC; Mesía R; Peyrade F; Budach W
Ann Oncol; 2011 Oct; 22(10):2191-200. PubMed ID: 21606209
[TBL] [Abstract][Full Text] [Related]
22. Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.
Chan AL; Leung HW; Huang SF
Clin Drug Investig; 2011 Oct; 31(10):717-26. PubMed ID: 21744880
[TBL] [Abstract][Full Text] [Related]
23. [Oncological treatment modalities in head and neck cancer].
Saarilahti K; Lindholm P
Duodecim; 2011; 127(18):1979-85. PubMed ID: 22034736
[TBL] [Abstract][Full Text] [Related]
24. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
Teoh DC; Rodger S; Say J; Hartley A
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
[No Abstract] [Full Text] [Related]
25. Cetuximab: its use in combination with radiation therapy and chemo-therapy in the multimodality treatment of head and neck cancer.
Wagner TD; Yang GY
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):76-83. PubMed ID: 18537749
[TBL] [Abstract][Full Text] [Related]
26. Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.
Robert F; Ezekiel MP; Spencer SA; Meredith RF; Bonner JA; Khazaeli MB; Saleh MN; Carey D; LoBuglio AF; Wheeler RH; Cooper MR; Waksal HW
J Clin Oncol; 2001 Jul; 19(13):3234-43. PubMed ID: 11432891
[TBL] [Abstract][Full Text] [Related]
27. Surgery after organ preservation therapy. Analysis of wound complications.
Sassler AM; Esclamado RM; Wolf GT
Arch Otolaryngol Head Neck Surg; 1995 Feb; 121(2):162-5. PubMed ID: 7840923
[TBL] [Abstract][Full Text] [Related]
28. Are anti-vitamin K drugs contraindicated with cetuximab during head-and-neck cancer concomitant radiotherapy?
Brohée D; Henry AR; Castadot P
Acta Clin Belg; 2013; 68(3):237-9. PubMed ID: 24156231
[TBL] [Abstract][Full Text] [Related]
29. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
Ye AY; Hay JH; Laskin JJ; Wu JS; Ho CC
J Cancer Res Ther; 2013; 9(4):607-12. PubMed ID: 24518704
[TBL] [Abstract][Full Text] [Related]
30. A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.
Adkins D; Ley J; Trinkaus K; Thorstad W; Lewis J; Wildes T; Siegel BA; Dehdashti F; Gay H; Mehan P; Nussenbaum B
Cancer; 2013 Feb; 119(4):766-73. PubMed ID: 22991252
[TBL] [Abstract][Full Text] [Related]
31. Cetuximab in the treatment of head and neck cancer.
Bernier J
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1539-52. PubMed ID: 17134359
[TBL] [Abstract][Full Text] [Related]
32. Cetuximab plus radiotherapy for head and neck cancer.
Ho AC
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
[No Abstract] [Full Text] [Related]
33. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.
Lavertu P; Bonafede JP; Adelstein DJ; Saxton JP; Strome M; Wanamaker JR; Eliachar I; Wood BG
Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):401-6. PubMed ID: 9559686
[TBL] [Abstract][Full Text] [Related]
34. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
Chan A; Teoh D; Sanghera P; Hartley A
Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
[No Abstract] [Full Text] [Related]
36. The role of cetuximab in the management of head and neck cancers.
Kabolizadeh P; Kubicek GJ; Heron DE; Ferris RL; Gibson MK
Expert Opin Biol Ther; 2012 Apr; 12(4):517-28. PubMed ID: 22413826
[TBL] [Abstract][Full Text] [Related]
37. Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience.
Jensen AD; Bergmann ZP; Garcia-Huttenlocher H; Freier K; Debus J; Münter MW
Head Neck Oncol; 2010 Nov; 2():34. PubMed ID: 21110844
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
Kuhnt T; Sandner A; Wendt T; Engenhart-Cabillic R; Lammering G; Flentje M; Grabenbauer G; Schreiber A; Pirnasch A; Dunst J
Ann Oncol; 2010 Nov; 21(11):2284-2289. PubMed ID: 20427347
[TBL] [Abstract][Full Text] [Related]
39. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies.
Vermorken JB; Herbst RS; Leon X; Amellal N; Baselga J
Cancer; 2008 Jun; 112(12):2710-9. PubMed ID: 18481809
[TBL] [Abstract][Full Text] [Related]
40. Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model.
Bozec A; Sudaka A; Toussan N; Fischel JL; Etienne-Grimaldi MC; Milano G
Ann Oncol; 2009 Oct; 20(10):1703-7. PubMed ID: 19542251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]